Jefferies analyst David Stanton downgrades Mesoblast (NASDAQ:MESO) from Buy to Hold.
What 7 Analyst Ratings Have To Say About Vistra
Vistra (NYSE:VST) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish…